The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Knowledge
Once NOUSCOM AG has claimed this profile, we'll publish editorial articles and case studies here together.
We're preparing industry comparisons that rank NOUSCOM AG by reviews, experience and specialisations.